May 12 is ME/CFS Awareness Day. Fuel progress all month long—join the May Momentum campaign!

BOSS-ME: Biological Outlier and Subtyping Software for ME/CFS

This project will develop a software tool to rapidly look for metabolism anomalies in an individual which might be explained by their genes. It will also look for potentially damaging genes in individuals and it will attempt to group ME/CFS patients based on their genetic and metabolic profiles.

Ocular Motor Study

The aim of this project is to fully characterise eye movement changes in ME/CFS on two consecutive days, identifying an ocular motor signature that is unique to the disorder.

Multi-Omics Study of ME/CFS (MAESTRO)

The primary goal of this project is to complete our comprehensive analysis of the genome, methylome, miRnome, and their interactions in order to fill the gaps in our understanding of ME/CFS pathophysiology and to identify clinically useful biomarkers.

Thrombospondin-1 (TSP-1)

Woman researcher conducting a VO2 Max test

Researchers are actively working to understand the role of Thrombospondin-1, an important biomarker, in those with ME/CFS.

Stress-Activated MicroRNAs

Studying microRNAs could help to bridge the conceptual gap between genetic predisposition and environmental factors causing ME/CFS or exacerbating specific symptoms.